Skip to main content
Terug
MNMD logo

Mind Medicine (MindMed) Inc.

Datakwaliteit: 100%
MNMD
NASDAQ Healthcare Biotechnology
€ 18,12
▼ € 0,29 (-1,55%)
Marktkapitalisatie: 1,37B
Dagbereik
€ 17,94 € 18,98
52-Weeksbereik
€ 4,70 € 19,62
Volume
28.226
50D / 200D Gem.
€ 12,71 / € 9,85
Vorige Slotkoers
€ 18,40

Koershistorie

Financiële Trends

Sectorvergelijking

vs Healthcare sector mediaan (626 peers)

Metriek Aandeel Sector Mediaan
P/E -7,5 0,4
P/B 4,1 2,9
ROE % -64,1 3,7
Net Margin % 3,8
Rev Growth 5Y % 10,0
D/E 0,0 0,2

Belangrijkste Punten

Debt/Equity of 0,00 — conservative balance sheet
Negative free cash flow of -131,56M

Groei

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
-64,06%
ROIC-37,53%
Net MarginN/A
Op. MarginN/A

Veiligheid

Debt / Equity
0,00
Current Ratio6,29
Interest Coverage-30,34

Waardering

P/E Ratio
-7,45
P/B Ratio4,12
EV/EBITDAN/A
Dividend Yield0,00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 0,0 Net Income (TTM) -183,79M
ROE -64,06% ROA -41,76%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -131,56M
ROIC -37,53% FCF Growth (3Y) N/A
Safety
Debt / Equity 0,00 Current Ratio 6,29
Interest Coverage -30,34 Dividend Yield 0,00%
Valuation
P/E Ratio -7,45 P/B Ratio 4,12
P/S Ratio N/A PEG Ratio -0,19
EV/EBITDA N/A Dividend Yield 0,00%
Market Cap 1,37B Enterprise Value 1,11B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 0,0 0,0 0,0 0,0 0,0
Net Income -183,79M -108,68M -95,73M -56,80M -93,04M
EPS (Diluted) -2,06 -0,15 -2,44 -1,84 -3,40
Gross Profit 0,0 -527.000,0 -3,16M -3,22M 0,0
Operating Income -166,31M -103,92M -93,87M -66,33M -93,85M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 440,10M 302,15M 124,54M 169,99M 164,00M
Total Liabilities 107,77M 60,70M 46,41M 19,08M 12,34M
Shareholders' Equity 332,33M 241,45M 78,13M 150,92M 151,66M
Total Debt 0,0 21,85M 14,13M 72.000,0 0,0
Cash & Equivalents 257,84M 273,74M 99,70M 142,14M 133,54M
Current Assets 419,32M 281,62M 103,87M 146,06M 137,22M
Current Liabilities 66,70M 38,85M 32,25M 17,89M 10,41M